newsfilter
← Latest News
PR Newswire·

Calliditas Q1 report, January - March 2024

Calliditas Therapeutics AB (NASDAQ: CALTX) (STOCKHOLM: CALTX): Target market expansion following full approval in the US JANUARY - MARCH 2024...